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Chapter
Plasmodium falciparum Protein 
Exported in Erythrocyte and 
Mechanism Resistance to Malaria
Neyder Contreras-Puentes
Abstract
Malaria is a tropical disease of parasitic origin transmitted by the Anopheles 
mosquito, caused by the protozoan of the genus Plasmodium. Around miles of 
people worldwide affected by disease, have been related the endemic develop-
ment of genetic alterations, called erythrocyte polymorphisms. These erythrocyte 
polymorphisms have become tools for resistance against malaria, where they have 
had an impact on the appearance of hemoglobinopathies, enzymatic alterations in 
erythrocytes, and modifications in the structure of erythrocytes related to mem-
brane proteins. These sections address a detailed approach to the resistance mecha-
nisms involved against the development of P. falciparum and develop a complete 
development of the principles of molecular principles that attempt to explain the 
functioning of these biochemical mechanisms and the development of the parasite.
Keywords: malaria, Plasmodium falciparum, erythrocyte, polymorphism, protein, 
hemoglobinopathies
1. Introduction
Malaria is one of the world’s most severe public health problems. It leads to 
high rates of morbidity and mortality in many underdeveloped countries, where 
children and pregnant women are the most affected groups. According to the World 
Malaria Report by the World Health Organization (WHO), 3.5 billion people from 
106 countries live in areas where they are in risk of transmission, representing half 
of the world’s population [1]. On the other hand, malaria caused an estimated 200 
million clinical episodes and 445,000 deaths, 90% of these deaths in Africa [2, 3]. 
Malaria is caused by parasites of the Plasmodium genus, which are intracellular 
eukaryotic organisms, with a complex life cycle. They commute between an inver-
tebrate transmitter vector, where the sexual stages develop, and a vertebrate host, 
where the asexual stages take place. P. falciparum is responsible for the severe forms 
of malaria and the majority of annual deaths [4, 5].
Human malaria clinical signs and symptoms are a direct consequence of the 
parasite’s life cycle. Humans are infected with P. falciparum sporozoites, through the 
female Anopheles mosquito’s bite. Each sporozoite reaches the liver through blood 
or lymphatic circulation and multiplies forming a liver schizont, which differenti-
ates into thousands of merozoites that are released into the bloodstream, after the 
schizont ruptures. Once released into the systemic circulation, the merozoites invade 
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Merozoite invasion process in human erythrocytes. Description of invasion and internalization of the P. 
falciparum parasite in the host cell. (1) The nascent parasitophorous vacuole. (2) Contact closed. (A) Initial 
contact of merozoite to erythrocyte. (B) The adhesion of the merozoite to the erythrocyte is observed, through 
the specific recognition and interaction of antigens and antibodies, as well as the functional and structural role 
of the micronemes and rhoptries. (C) Process of invasion and development of the parasitophorous vacuole. (D) 
The internalization of the merozoite in the new host cell and the complete formation of the parasitophorous 
vacuole are detailed. Taken and adapted from Zuccala and Baum [30].
Figure 1. 
Life cycle of Plasmodium spp. A. Exoerythrocytic cycle (1). Anopheles mosquito inoculates the sporozoites with 
subsequent invasion in liver cells (2); generation of first pre-erythrocytic schizogony (3). B. Erythrocytic cycle. 
The rupture of the schizont (4) releases the merozoites into the bloodstream where they invade red blood cells 
(5) forming a trophozoite that ripens into schizont, whose rupture releases merozoites back into the torrent (6). 
Some trophozoites can mature into gametocytes (7) that are ingested by the mosquito (8). C. Sporogonic cycle. 
The gametocytes mature to macrogametes and flagellated microgametes (9) that, after fertilization, produce 
an ooquineto (10), which migrates from the mosquito to generate oocyst (11) that will release thousands of 
sporozoites (12). Adapted from http://www.dpd.cdc.gov/dpdx/HTML/ImageLibrary/Malaria_il.htm.
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the red blood cells and initiate the intra-erythrocyte stage, which lasts approximately 
48 hours. Immediately after the invasion, the growth and development staging 
begins first as rings (0–24 h), then as trophozoites (24–40 h), and finally as schizonts 
(40–48 h); the cycle ends with the host cell destruction and the release of new mero-
zoites from circulating erythrocytes, then initiating another cycle [6] (Figure 1).
During the development and growth stages, the parasite causes successive changes 
in the architecture of the infected erythrocyte (remodeling), which are fundamental 
for its vital functions. These changes are the acquisition of extracellular environment 
nutrients, the attribution of cytoadhesive properties that contribute to spleen-clearance 
evasion, the generation of changes in the host membrane cytoskeleton that are neces-
sary for efficient parasite progeny release, and the formation of new organelles, such as 
the Maurer’s clefts, tubulovesicular network, and the parasitophorous vacuole mem-
brane (PVM) (Figure 2) [7, 8]. When the parasite enters the erythrocyte, it locates 
inside a parasitophorous vacuole (PV), which isolates it from the host cell cytoplasm, 
through the PVM. From then on, pathogen survival will depend on the efficient traffic 
of the molecules through the PVM and the plasma membrane [4, 9].
2. Human erythrocyte: properties of the human erythrocyte membrane
The erythrocyte is a cell of approximately 8 μm in diameter, highly special-
ized in O2 and CO2 transportation, without a nucleus and other organelles, useful 
for protein synthesis. It has the ability to transit the bloodstream over a 120-days 
lifetime. In addition, it has a remarkable capacity for deformability that allows its 
movement through the capillary microcirculation and splenic endothelial clefts in 
approximately 1 μm diameter [10]. The erythrocyte elastic properties are due to the 
cytoskeleton membrane, which is formed by an array of regular hexagonal proteins 
which makes up a two-dimensional mesh on the cell’s cytoplasmic surface. These 
structural proteins interact with membrane lipids to maintain fluidity and subdi-
vide them into three protein types: cytoskeleton, integral, and anchor [11].
The membrane cytoskeleton proteins underlie just under the lipid bilayer and 
associate with other proteins, forming a dynamic protein network, responsible 
for maintaining the integrity of the erythrocyte, as it passes through narrow 
blood capillaries. Spectrin, actin, adducin, dematin, band 4.1, tropomyosin, and 
tropomodulin are within this group. Integral proteins are characterized for being 
embedded in the lipid bilayer and presenting intra and extracellular domains, such 
Figure 3. 
Mechanisms of HbAS-related protection against P. falciparum. Adapted of Bunn [81].
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as band 3 and glycophorin A and C. Finally, anchoring proteins have the function of 
connecting the cytoskeleton proteins with integral proteins, such as ankyrins and 
band 4.2 proteins [12, 13].
3.  Erythrocyte and merozoite membrane proteins: participate in  
P. falciparum invasion process
The remodeling of the structures of the human erythrocytes for parasite of the 
malaria is generated between the process of invasion of merozoites. During the pro-
cess, the parasite induces a transitory alteration of the structure of the membrane 
of the host cell, binging sites of the surface cellular [14]. More than 50 P. falciparum 
proteins have been identified which induce the process of invasion; however, some 
functional classes of elements such as merozoite surface protein (MSPs) have been 
described, which have demonstrated a structural complex around the envelope of 
the merozoites, related to PfEBAs (P. falciparum erythrocyte binding antigens) and 
PfRHs (P. falciparum reticulocytes binding protein), which are able of save organ-
elles as micronemes and rhoptries [15–17].
In general, the erythrocyte membrane changes are set in motion with the mero-
zoite invasion process. It has been described that the initial interaction between the 
merozoite and erythrocyte is probably a random collision, depending on the func-
tion of actin-myosin binding and specific molecular interactions between merozoite 
ligands and erythrocyte membrane receptors, which mediate cellular recognition 
and invasion of red blood cells [18]. This invasive process is carried out in four steps. 
The first step, called the initial contact with merozoite, takes place mainly by the 
interaction of proteins that are uniformly distributed on the surface of the merozo-
ite, called glycosyl-phosphatidyl-inositol protein (GPI), with erythrocyte surface 
ligands, such as merozoite surface protein 1 (MSP1), whose receptor is band 3 pro-
tein in the erythrocyte membrane [19, 20]. The second step is called reorientation, 
which is produced for vertical arrangement of apical secretory organelles, such as 
rhoptries and micronemes. This step is mediated by a protein called apical membrane 
Antigen-1 (AMA1), which seems to establish the apical interaction of the adhesins 
with the erythrocyte; it is the border point between the weak union that occurs in the 
initial contact with MSP1 and irreversible bonds that occur between microneme pro-
teins and erythrocyte membrane proteins [21, 22]. The third step is the tight-binding 
formation between various adhesins produced at the apical end of the parasite and 
its membrane receptors in the red blood cell, where the Duffy binding-like proteins 
(DBL) and reticulocyte binding proteins (RBP) bind. For example, surface DBL 
proteins of merozoite EBA 175 and EBA 140 (erythrocyte binding antigen 175 and 
140) bind to erythrocyte membrane sialoglycoproteins, such as glycophorin A and 
C [23, 24]. On the other hand, while PfRh proteins bind to complement receptor 1 
(CR1), signalization established by sensitive chymotrypsin receptor pathway and 
resistant to neuraminidase takes place [23, 25]. Once the parasite and erythrocyte 
tight junction is established, intake is mediated by the actin-myosin motor activation 
on the merozoite surface. This coincides with lipid and protein secretion, such as 
organelle-released proteases called rhoptries, micronemes, and mononemes. These 
proteases are associated to perform integral membrane proteins cleavage, such as 
band 3 and rupture of the membrane cytoskeletal proteins [26, 27].
During the invasion, proteins from the rhoptries and dense granules are secreted 
into the parasitophorous vacuole, and once it has developed to the ring phase, 
these proteins are exported to the cytoplasm of the infected erythrocyte to trig-
ger the succession of effects of remodeling at the level of the host cell. It has been 
established that P. falciparum is capable of associating with Knobs, which are related 
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to Knobs-proteins rich in histidines (KHARP). This type of formations allows the 
presentation of cytoadherence proteins exported by the parasite, which are coupled to 
the membrane, as is the case in particular of P. falciparum of erythrocyte membrane 
protein 1 (PfEMP1) [27].
Subsequently, the parasite invaginates the erythrocyte through a protein-free 
zone and initiates the formation of parasitophorous vacuole, which continues with 
a motility mechanism to enter the host cell. Rhoptries and dense granules secrete 
proteins during the invasion early ring phase, which are trafficked to different 
structures, such as parasitophorous vacuoles, cytosol, and erythrocyte membrane, 
triggering a series of events that modify the host cell [28].
4. P. falciparum export proteins modify the erythrocyte membrane.
Once inside the erythrocyte, P. falciparum is subjected to a trophic phase, followed 
by a replicative phase. The parasite modifies the host cell during the intra-eryth-
rocytic period, conditioning it as its new habitat. It induces the formation of new 
permeability pathways, allowing it to provide itself with essential nutrients, dispose 
of waste products, modify the electrolytic composition, and decrease the colloid 
osmotic pressure of the erythrocyte, in order to survive in this new environment [29].
The infected erythrocyte enlarges in size, developing the formation of parasi-
tophorous vacuole (PV), parasitophorous vacuole membrane (PVM), new mem-
branous structures, such as the Maurer’s clefts (MC), tubulovesicular networks 
(TVN), and erythrocyte surface protrusion appearance called Knobs. Moreover, 
new type of channels in the PVM and alterations of the erythrocytic membrane 
channels are formed, in which virulence proteins are trafficked [7, 29, 30]. In 
addition to MC and TVM, other structures have been described, which are involved 
in export protein trafficking, such as electron-dense vesicles (EDV), vesicle-like 
structures (VLS), J points or J-Dots, named for J-domain proteins [31–34].
Figure 4. 
Glucose-6-phosphate dehydrogenase (G6PD) pathway. G6PD, glucose-6-phosphate dehydrogenase, GPX, 
glutathione peroxidase; GR, glutathione reductase, 6PG, 6-phosphogluconate dehydrogenase; GSH, glutathione 
reduced; GSSG: glutathione oxidized. Adapted from Cappellini and Fiorelli [92].
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Another host cell modification refers to P. falciparum infected erythrocyte cytoad-
herence to endothelial cells, resulting in a sequestration of mature parasites in capil-
laries and microvasculature [35]. The sequestration probably leads to microcirculation 
alterations and metabolic dysfunctions, which could be responsible for severe malaria 
manifestations [36]. The cytoadherence to endothelial cells confers at least two advan-
tages for the parasite: (1) a more suitable microaerophilic environment for parasite 
metabolism and (2) evasion to splenic circulation, where infected erythrocytes would 
be destroyed [36–39]. P. falciparum exports its proteins to the erythrocyte cytoplasm, 
where it binds to cytoskeletal components and alters the natural interactions of the 
membrane structural proteins, in order to achieve these major changes in the erythro-
cyte structure. Export proteins are encoded by 8% of P. falciparum parasite genome. 
It corresponds to host cell exported proteins, both in asexual and gametophytic 
phases. Table 1 lists the main P. falciparum export proteins, which participate in the 
remodeling process and present PEXEL motifs. However, non-PEXEL proteins such 
as PfEMP1, SURFIN, and Pf332 are also shown in Table 1, due to their importance in 
the infected erythrocyte remodeling process, but only PfEMP1.
5.  Mechanism of resistance to malaria and effect of P. falciparum in 
erythrocyte
Parasites of the genus Plasmodium have co-evolved over 200 million years with 
the human species [55]. In this way, the increase of migrations in multiple regions 
and the establishment of settlements in certain areas have influenced the increase 
in endemicity produced by the successive exposure of the etiological agent of the 
disease; this high effect of selective pressure of the parasite has co-influenced the 
development of genetic variations linked to endemic populations, from which they 
have emerged over time polymorphic variants in erythrocytes in order to respond 
to the most severe symptoms of the disease, hindering the survival of the parasite 
or preventing the development of its entire life cycle. Many of these variations may 
be due to changes in structural proteins of the erythrocyte, alterations in hemoglo-
bin (thalassemia’s and sickle cell anemia), or an incidence in the quantitative and 
functional level of enzyme activity involved in oxidative processes such as G6PD or 
pyruvate kinase [56, 57].
Currently, a global distribution of erythrocyte polymorphisms has been 
described, such as hemoglobinopathies (thalassemia’s, HbS, HbC, and HbE) and 
enzymatic alterations such as glucose-6-phosphate dehydrogenase deficiency 
(G6PD), which have their origin in response to the selective pressure exerted by 
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Table 1. 
Proteins from the export of P. falciparum that modify post-invasion erythrocyte [6, 9].
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malaria parasites on humans during the last 70,000 years [58]. Therefore, hemo-
globinopathies and erythroenzymopathies have been attributed to different mecha-
nisms that provide protection against severe manifestations of malaria; some of the 
relevant mechanisms are associated with reduced erythrocyte invasion, decreased 
intraerythrocytic growth, increased phagocytosis in infected erythrocytes, and 
increased immune response against parasitized erythrocytes [59]. Therefore, this 
type of erythrocyte polymorphisms can be related to resistance to malaria through 
immune mechanisms that can be a major health problem, due to the high frequency 
of carriers in endemic areas of malaria, mainly in the African continent where this 
It seriously affects the normal development of populations. Therefore, this type of 
genetic variants was originally characteristic of the tropics and subtropics; nowa-
days, there is a high dispersion in the whole world, product of the continuous migra-
tions that induce an increased effect of the prevalence values of these diseases [60].
5.1 Hemoglobinopathies
Hemoglobinopathies are a group of genetic alterations that involve a change in 
some of the subunits of hemoglobin and present an autosomal recessive inheritance 
pattern [61, 62]. These are divided into structural hemoglobinopathies, produced by 
the simple substitution of amino acids in the α and β chains of hemoglobin and thalas-
semic syndromes, which are manifested by the total or partial decrease in the synthesis 
of a globin chain [63]. The frequency of these polymorphisms in the world population 
and their geographical distribution are highly variable. In the case of hemoglobinopa-
thies, it is estimated that every year more than 300,000 children with severe forms 
of these diseases are born worldwide, most of them in countries of low and medium 
income [64, 65]. Approximately 5% of the world population carries a sickle cell or 
thalassemia gene, and in some regions, the percentage of carriers can reach 25%. 
Approximately 60–70% of all births of children with some serious alteration of hemo-
globin (Hb) occurs in Africa, being the sub-Saharan region the most affected [66, 67].
5.1.1 Hemoglobin S
Hemoglobin S (HbS) is associated with a mutation in the β-globin gene where 
there is a change of thymine by adenine, thus coding a valine instead of glutamic 
acid (Glu6Val, βS). This mutation produces a hydrophobic modification in the 
deoxygenation of the Hb tetramer, which results in the union between the beta-1 
and beta-2 chains of the two hemoglobin molecules (Hb). This union produces a 
polymer nucleus, which grows and invades erythrocytes, affecting architecture and 
flexibility and influencing cellular dehydration, with physical and oxidative cellular 
stress [68]. HbS is a hereditary trait that follows an autosomal recessive pattern, and 
therefore, it can present in a homozygous (HbSS) or heterozygous (HbAS) form. 
The HbSS form causes sickle cell anemia (SCA), while the heterozygote is consid-
ered a carrier of the trait [69].
It is estimated that around of 300 million people in the world, are diagnosed 
with sickle cell trait (SCT) a greater presence in Africa and the Mediterranean 
region, where the endemic areas of malaria are related to the occurrence of these 
hemoglobinopathies. In the United States, the prevalence of sickle cell traits is 
estimated at 8% for African-Americans and 0.05% for white Americans, suggesting 
an approximate incidence of 7.9 per 100,000 births. [70, 71].
At the metabolic level, it has been described that an increase in the production of 
ROS in the erythrocytes of individuals carrying the sickle trait shows a behavior simi-
lar to senescent erythrocytes. This phenomenon describes that aging causes eryth-
rocyte cytosolic changes that affect antioxidant functioning, which can lead to the 
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generation of a redox imbalance and induce the hemolysis and toxic accumulation of 
heme and Hb in the plasma [72, 73]. This oxidative imbalance tends to be even greater 
in the erythrocytes of carrier individuals, a process that increases in cytosolic and 
membrane transformations due to the decrease in its half-life. Hence, the infection 
of HbAS erythrocytes with malaria parasites causes an increase in the redox imbal-
ance associated with the metabolic activity of the pathogens. However, the molecular 
effects of this imbalance are not fully established and therefore it is necessary to 
continue with their study to establish their role in the parasitic-host relationship.
Equally, have been suggested mechanisms which the sickle cell protects against 
malaria as shown by Pasvol et al., where an inhibition of growth of the parasite due 
to the polymerization of HbS and effect related with low oxygen levels is presented 
[74, 75]. Recently, Archer et al. demonstrated that infected erythrocytes HbAS 
showed a decrease in oxygen levels affecting the intracellular growth. These inves-
tigations have evidenced that growth inhibition produced by HbS-polymerized 
increments the cytoadherence, a condition favorable for inducing a reduction in the 
development of parasites [76].
Other mechanisms related have evidenced morphologic modifications in eryth-
rocyte due to aberrant expression of PfEMP1 able of affect the binding of infected 
RBCs to host cells, and induce the diminution of virulence through the reduction 
of rosette formation and decreased cytoadherence [77]. Also, it has been described 
that the generation of antibodies against band-3 protein may be associated with 
formation of aggregated band-3 with impact in new sites for endothelium adhesion 
on erythrocyte with such polymorphisms and finally able cause conformational 
changes in band-3. Alike, it has been demonstrated that the parasite remodels the 
interaction of actin-cytoskeleton binding to enable the export of parasite-derived 
proteins to knobs on the parasitized RBC surface [58] Figure 3.
Thus, the mechanism established that during the invasive step in sickle cell, 
all are affected to a phenomenon of oxidative stress. This increase in ROS induces 
phagocytosis phenomenon related with hemoglobin denaturation, formation 
and hemichrome binding, aggregation protein as band 3 protein, development of 
antibody and it deposition, and binding of complement C3c fragments [78].
In this way, the increase of phagocytosis processes in HbAS erythrocytes 
infected with P. falciparum is remarkably advantageous for the host, in which a suc-
cession of associated mechanisms is triggered such as growth reduction and popula-
tion density of parasites, young forms of the parasite are rapidly eliminated by the 
immune response, and it has been observed that mature forms (trophozoites and 
schizonts) adhere to the endothelium in smaller proportion in important organs 
(lungs, kidneys, brain, bone marrow, and placenta), which has led to a decrease 
in the severe symptoms of the disease (cerebral malaria, placental malaria, and 
respiratory disorders) [79, 80].
On the other hand, some molecular mechanisms have been established which 
have included the concept of microRNA (miRNAs). The development in cultures 
have founded the action of two miRNAs, miR-451 and let-7i, regulating of growth 
of parasites. Likewise, the incidence of miR-451 and let7i have induced reduction 
of parasitemia and a notable effect in the incorporation of hypoxanthine producing 
changes in characteristic of erythrocyte and defects during invasion of parasite, 
which have been associated with high specificity of sequences of miRNAs with 
anti-parasite function.
5.1.2 α- and β-thalassemia
During much time, the association between α-thalassemia and malarial protec-
tion mechanism has been studied, reporting the presence of the α + variety in the 
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studied population [82]. The α-thalassemia is able to induce hemolytic state and 
be associated with a reduction in erythrocyte survival, with an increased eryth-
rocyte in circulating young erythrocytes [83]. The α-thalassemia is very common 
in malaria-endemic regions; it is considered to confer protection against clinical 
manifestations of the disease induced by P. falciparum. In vitro studies have evi-
denced that in α-thalassemic erythrocytes infected with Plasmodium, high levels 
of antibodies develop from their surface. Additionally, activation mechanisms in 
opsonized erythrocytes, complement-induced lysis and inhibition of sequestration 
of infected erythrocytes have been associated, which result as anti-malarial mecha-
nisms that might be promoted by such antibodies [84, 85].
In other studies, the roles of microcytosis have been associated with the 
protection from P. falciparum-related hemoglobin decrease; in patients, a reduc-
tion of infection for part of parasite and most notary in homozygous α-thalassemic 
individuals have been evidenced, where a decline of hemoglobin levels, is observed 
and likewise, microcytosis is related with oxidative stress induced in altered 
erythrocytes with the presence of thalassemia and iron-deficiency. Finally, could 
be linked a development of process as low resetting in infected microcytic RBCs 
[86]. Likewise, α-thalassemia protects against severe malaria by attenuating the 
effect of parasite virulence and decreasing the amount of Hb loss during increased 
parasitemia. The α-thalassemia erythrocytes parasitized may be more susceptible 
to phagocytosis in vitro culture and unavailable than normal red cells in the 
formation of rosettes [87, 88]. Alike, has been related the complement receptor 1 
(CR1), which is reduced on α-thalassemic erythrocytes infected, the diminution 
of CR1 expression in this type of cells are associated with a possible mechanism for 
reduction resetting [89]. Following, with less able to adhere to endothelial cells. Of 
this mode, studies have suggested that altered cells maintain that membrane band 
3 may be a target for enhanced antibody binding to parasitized a-thalassemic cells 
[90, 91].
6. Erythroenzymopathies
6.1 Glucose-6-phosphate dehydrogenase deficiency (G6PD)
Worldwide, one of the most frequent polymorphic disorders at the level of 
erythrocytes is the deficiency of glucose-6-phosphate dehydrogenase (G6PD), a 
condition that is triggered by the decrease in the activity of glucose-6-phosphate 
dehydrogenase [92]. This disorder linked to genetics is located in the terminal 
region of the long arm of chromosome X (Xq28) and characterized by establish-
ing the condition of deficiency or normal in men; and in the case of women, it is 
established that they can be heterozygous, homozygous, or normal [92, 93]. The 
heterozygous women have a copy of the gene that synthesizes the normal G6PD and 
another copy that produces the variant of the enzyme.
The active enzyme consists of identical subunits that form dimers and tetra-
mers, which contain a nicotinamide-adenine dinucleotide phosphate (NADP) 
binding site [94, 95]. NADP binds to the enzyme, as a structural component and 
as a substrate for the reaction. As shown in Figure 4, G6PD catalyzes the entry of 
glucose-6-phosphate (G6P) into the pentose phosphate pathway, specifically that of 
hexose monophosphate, a reaction that produces glucose-6 oxidation, phosphate to 
6-phosphogluconolactone, reducing NADP to NADPH [96].
In erythrocytes, it is the only source of NADPH, being essential to protect cells 
against physiologically high levels of oxidative damage, enzymatic mechanisms 
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associated with increases in reduced glutathione (GSH) [92]. Where glutaredoxin 
intervenes and by means of which GSH protects the sulfhydryl groups of the hemo-
globin and the erythrocyte membrane, but in the presence of oxidizing agents, in 
the form of free radicals or peroxides, the level of GSH decreases, although it can 
be restored by the action of glutathione reductase which does have an adequate 
NADPH supplement [75].
Wide mechanisms have been described for the study of role of G6PD-
deficiency as elements protective during infection with P. falciparum. The distribu-
tion in the world with respect to malaria is similar to the mutated alleles G6PD; 
these observations have evidenced that first studies evaluated the connection 
between G6PD deficiency and malaria, with contradictory results. However, 
the allelic heterogeneity of G6PD deficiency may be related with susceptibility 
of P. falciparum when infected erythrocytes are present under this condition. 
Thereby, studies established by Ruwende and col. have demonstrated that G6PD 
A- alleles are associated with a reduction in the risk of severe malaria caused by 
P. falciparum, protection that are confer principally in heterozygote individuals 
[97]. Likewise, experimental investigations have evidenced a diminution in the 
growth of parasitized-erythrocytes with G6PD A and A- in Mediterranean popula-
tion when contrast with normal subject. Thus, this has indicated the incidence of 
mechanism of initial phagocytosis, where infected RBC of G6PD-deficicients is 
induced to phagocytosis by macrophages in anterior stages of the development of 
parasite, an aspect that is related with protective mechanism against malaria [98, 
99]. Equally, a direct relationship of activation of process as phagocytosis in ring 
stages of parasite in erythrocytes infected with this condition has been considered 
[99]. This mechanism is associated with an increased binding of autologous IgG 
and complements C3 fragments when were compared with infected-RBC normal 
individuals [100]. Finally, have been associated a succession of phenomena’s as the 
oxidation under increase of ROS into the erythrocytes and formation aggregated of 
band-3 protein [101].
6.2 Pyruvate kinase deficiency (PK)
Pyruvate kinase (PK) is an enzyme engaged in the conversion of phosphoenol-
pyruvate (PEP) to pyruvate. The catalysis of PK is an important element for forma-
tion of ATP in the glycolytic route [102]. PK plays a fundamental role in erythrocyte 
due to which cells depend on the production of ATP by glycolysis for the metabolic 
development and functionality of the cells [103]. The PK activity generally is 
increased in erythrocytes in the infection process. Likewise, have been associated 
to recognizing and the generation of the target of drug with P. falciparum infec-
tion [104]. PK deficiency is enzymatic alteration of the glycolytic route inducing 
non-spherocytic hemolytic anemia. The cause frequently linked is due to punctual 
mutations (1529A and 1456 T). PK deficiency presents worldwide distribution and 
is commonly prevalent in Caucasian populations [105].
It has been shown that PK deficiency is related to protection against infection in 
mice with Plasmodium chabaudi parasites, suggesting a similar effect of PK defi-
ciency in humans. These effects have shown that PK-deficient human erythrocytes 
have induced diminution of malaria infection [106]. Other reports have indicated 
that possibly a protective effect against P. falciparum infection is generated, with 
alterations associated to replication on infected erythrocytes, where an invasive 
defect of erythrocytes in subjects bearing the homozygous mutation and to a 
preferential macrophage clearance of ring-infected erythrocytes is evidenced both 
in homozygous and heterozygous individuals [107].
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Some phenomena have been associated with the deficiency of pyruvate kinase 
and infected erythrocytes, such as those established by the pleiotropic effect of the 
enzyme deficiency in the invasion of the parasite, which favors a substantial reduc-
tion of the growth of these and in the same way observes the activation of processes 
such as phagocytosis of infected erythrocytes in the ring stage that can provide 
protection against malaria, either by causing a reduction in the parasite burden or 
by reducing the number of erythrocytes infected with parasites in the trophozoites 
stages and schizonts that are available to join microvascular beds of vital organs [108].
These result in a reduced level of invasion of P. falciparum and erythrocytes of 
subjects with homozygous mutations. We also indicated that the possible biochemi-
cal differences in the intracellular medium, including the accumulation of glycolytic 
metabolic intermediates, did not cause a difference in the growth of parasites in 
erythrocytes between homozygotes and heterozygotes [109, 110]. To know even 
more the hypotheses of the reduction of the invasion observed in the erythrocytes 
of the subjects with homozygous mutations, it is also due to the capacity of the 
parasite, including the altered development of merozoites, the invasion of erythro-
cytes by merozoites was examined. It has been observed that the erythrocyte-tale 
merozoites had normal levels of invasion and replication in the erythrocytes of the 
control subjects [110].
We examined the phagocytic uptake of infected erythrocytes with P. falciparum 
(ring phase and mature phase) of case and control matter. Phagocytosis of infected 
erythrocytes in the ring stage of patients with homozygous mutations was higher 
than phagocytosis of uninfected erythrocytes. Also, an increased clearance has been 
observed by macrophages of erythrocytes infected in the ring stage of the parasite 
derivatives and heterozygotes for the PKLR mutation [108, 110].
Finally, it has led to establish that infected erythrocytes under this condition 
had a greater phagocytic phenomenon related to the development and deposition of 
hemichromes, IgG, and complement C3c [111, 112].
7. Conclusions
Malaria for years has been a study approach for scientists in the approach to the 
structural and functional study of the constituent proteins of the etiological agent, 
Plasmodium falciparum. A description of important proteins of the parasite has 
been established, as well as an approach of the main experimental studies that try to 
explain the molecular basis of each of the main erythrocyte polymorphisms shows 
a direct and significant resistance against the development of the parasite, and in 
this way, structural supports and detailed knowledge of some of these polymorphic 
modifications that show a complete field of study that will lead to the increasingly 
broad development of new tools for the compression and search for new pharmaco-
logical therapies are provided.
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AMA1 apical membrane antigen-1
CAT catalase
CR1 complement receptor 1
C3c complement component C3c












KHARP Knobs-proteins rich in histidines
mi-RNA micro-ribonucleic acid
MSP1 merozoite surface protein 1
NADP nicotinamide-adenine dinucleotide phosphate
PV parasitophorous vacuole
PVM parasitophorous vacuole membrane
PfEMP1 Plasmodium falciparum erythrocyte membrane protein 1
PKLR pyruvate kinase isozymes R/L
PK pyruvate kinase
ROS reactive oxygen species
RBP reticulocyte binding proteins
SCT sickle cell trait
TVN tubulovesicular networks
Please use Adobe Acrobat Reade  o read this book chap er for free.
Just open this sam  document with Adobe Reader.
If you do not have it, you can download it here.
You can freely access the chapter at the Web Viewer here.
Securing Connection...Acrobat is l cking docum n loading.com
r




[1] World Health Organization. World 
Malaria Report [Internet]. World 




[2] De Mast Q , Brouwers J, Syafruddin D, 
Bousema T, Baidjoe AY, De Groot PG, 
et al. Is asymptomatic malaria really 
asymptomatic? Hematological, 
vascular and inflammatory effects of 
asymptomatic malaria parasitemia. The 
Journal of Infection. 2015;71(5):587-596. 
DOI: 10.1016/j.jinf.2015.08.005
[3] Bardach A, Ciapponi A, Rey-Ares L, 
Rojas JI, Mazzoni A, Glujovsky D, 
et al. Epidemiology of malaria in Latin 
America and the Caribbean from 
1990 to 2009: Systematic review and 
meta-analysis. Value in Health Regional 
Issues. 2015;8:69-79. DOI: 10.1016/j.
vhri.2015.05.002
[4] Goldberg DE, Cowman AF. Moving 
in and renovating: Exporting 
proteins from Plasmodium into 
host erythrocytes. Nature Reviews. 
Microbiology. 2010;8:617-621. DOI: 
10.1038/nrmicro2420
[5] Tilley L, Dixon MWA, Kirk K. The 
Plasmodium falciparum-infected red 
blood cell. The International Journal 
of Biochemistry & Cell Biology. 
2011;43(6):839-842. DOI: 10.1016/j.
biocel.2011.03.012
[6] Maier AG, Cooke BM, Cowman AF, 
Tilley L. Malaria parasite proteins that 
remodel the host erythrocyte. Nature. 
2009;7(5):341-54
[7] Mundwiler-pachlatko E, Beck H, 
Charles S, Alphonse L. Maurer’s clefts, 
the enigma of Plasmodium falciparum. 
PNAS. 2013;110(50):19987-19994
[8] Spycher C, Rug M, Klonis N, 
Ferguson DJP, Cowman AF, Beck H-P,  
et al. Genesis of and trafficking to 
the Maurer’s clefts of Plasmodium 
falciparum-infected erythrocytes. 
Molecular and Cellular Biology. 
2006;26(11):4074-4085. DOI: 10.1128/
MCB.00095-06
[9] Prajapati SK, Singh OP. Blood cells, 
molecules and diseases remodeling 
of human red cells infected with 
Plasmodium falciparum and the impact of 
PHIST proteins. Blood Cells, Molecules 
& Diseases. 2013;51(3):195-202. DOI: 
10.1016/j.bcmd.2013.06.003
[10] Mohandas N, Gallagher PG. ASH 
50th anniversary review red cell 
membrane: Past, present, and future. 
Blood. 2009;112(10):3939-3948
[11] Tomaiuolo G. Biomechanical 
properties of red blood cells in health 
and disease towards microfluidics. 
Biomicrofluidics. 2014;8(5):1-19. DOI: 
10.1063/1.4895755
[12] Lu Y, Liu J. Erythrocyte membrane 
proteins and membrane skeleton. 
Frontiers of Biology in China. 
2007;2(3):247-255
[13] Kakhniashvili D, Bulla L, 
Goodman S. The human erythrocyte 
proteome: Analysis by ion trap mass 
spectrometry. Molecular & Cellular 
Proteomics. 2004;3(5):501-509
[14] Wright GJ, Rayner JC. Plasmodium 
falciparum erythrocyte invasion: 
Combining function with immune 
evasion. PLoS Pathogens. 2014;10(3):1-7
[15] Mazumdar S, Mukherjee P, Yazdani 
SS, Jain SK, Mohmmed A, Chauhan 
VS. Plasmodium falciparum merozoite 
surface protein 1 (MSP-1)-MSP-3 
chimeric protein: Immunogenicity 
determined with human-compatible 
adjuvants and induction of protective 
immune response. Infection and 
Immunity. 2010;78(2):872-883
Ple se use Adobe Acrobat Reader to read this book chapter for free.
Just open this same document with Adobe Reader.
If you do not have it, you can download it here.
You can freely access the chapter at the Web Viewer here.
Securing Connection...Acrobat is locking documen loading.com
r
File cannot be found.
15
Plasmodium falciparum Protein Exported in Erythrocyte and Mechanism Resistance to Malaria
DOI: http://dx.doi.org/10.5772/intechopen.83700
[16] Das S, Hertrich N, Perrin AJ, 
Withers-Martinez C, Collins CR, 
Jones ML, et al. Processing of 
Plasmodium falciparum Merozoite 
surface protein MSP1 activates a 
Spectrin-binding function enabling 
parasite egress from RBCs. Cell Host 
& Microbe. 2015;18(4):433-444. DOI: 
10.1016/j.chom.2015.09.007
[17] Beeson JG, Drew DR, Boyle MJ, 
Feng G, Fowkes FJI, Richards JS. 
Merozoite surface proteins in red blood 
cell invasion, immunity and vaccines 
against malaria. FEMS Microbiology 
Reviews. 2016;40(3):343-372
[18] Cowman AF, Crabb BS. Invasion of 
red blood cells by malaria parasites. Cell. 
2006;124(4):755-766
[19] Kinoshita T. Glycosylphosphati-
dylinositol (GPI) anchors: Biochemistry 
and cell biology: Introduction to a 
thematic review series. Journal of Lipid 
Research. 2016;57(1):4-5. DOI: 10.1194/
jlr.E065417
[20] Srinivasan P, Beatty WL, Diouf A, 
Herrera R, Ambroggio X, Moch JK, 
et al. Binding of Plasmodium merozoite 
proteins RON2 and AMA1 triggers 
commitment to invasion. Proceedings 
of the National Academy of Sciences. 
2011;108(32):13275-13280. DOI: 
10.1073/pnas.1110303108
[21] Yang ASP, Lopaticki S, O’Neill MT, 
Erickson SM, Douglas DN, Kneteman 
NM, et al. AMA1 and MAEBL are 
important for Plasmodium falciparum 
sporozoite infection of the liver. Cellular 
Microbiology. 2017;19(9):e12745
[22] Tolia NH, Enemark EJ, Sim BKL, 
Joshua-tor L. Structural basis for the 
EBA-175 erythrocyte invasion pathway 
of the malaria parasite Plasmodium 
falciparum. Cell. 2005;122:183-193
[23] Lopaticki S, Maier AG, 
Thompson J, Wilson DW, Tham WH, 
Triglia T, et al. Reticulocyte and 
erythrocyte binding-like proteins 
function cooperatively in invasion 
of human erythrocytes by malaria 
parasites. Infection and Immunity. 
2011;79(3):1107-1117
[24] Li X, Marinkovic M, Russo C, 
McKnight CJ, Coetzer TL, Chishti AH. 
Identification of a specific region of 
Plasmodium falciparum EBL-1 that 
binds to host receptor glycophorin 
B and inhibits merozoite invasion 
in human red blood cells. Molecular 
and Biochemical Parasitology. 
2012;183(1):23-31
[25] Richard D, Macraild CA, 
Riglar DT, Chan J, Foley M, Baum J, 
et al. Interaction between Plasmodium 
falciparum apical membrane antigen 1 
and the Rhoptry neck protein complex 
defines a key step in the erythrocyte 
invasion process of malaria parasites. 
The Journal of Biological Chemistry. 
2010;285(19):14815-14822
[26] Méndez D. Proteómica Redox De 
Membrana De Eritrocito Humano En 
Malaria Y Polimorfismos De Grupos 
Sanguíneos Y G6PD. 2011
[27] Mbengue A, Yam XY, Braun-Breton 
C. Human erythrocyte remodelling 
during Plasmodium falciparum 
malaria parasite growth and egress. 
British Journal of Haematology. 
2012;157(2):171-179
[28] Morse D, Webster W, Kalanon M, 
Langsley G, McFadden GI. Plasmodium 
falciparum Rab1A localizes to rhoptries 
in schizonts. PLoS One. 2016;11(6):1-13
[29] Lang PA, Kasinathan RS, Brand VB, 
Lang C, Koka S, Shumilina E, et al. 
Accelerated clearance of Plasmodium-
infected erythrocytes in sickle cell 
trait and Annexin-A7 deficiency. 
Cellular Physiology and Biochemistry. 
2009;24:415-428
[30] Zuccala ES, Baum J. Cytoskeletal 
and membrane remodelling during 
Please use Adobe Acrobat Reade  o read this book chap er for free.
Just open this sam  document with Adobe Reader.
If you do not have it, you can download it here.
You can freely access the chapter at the Web Viewer here.
Securing Connection...Acrobat is l cking docum n loading.com
r
File cannot be found.
Malaria
16
malaria parasite invasion of the 
human erythrocyte. British Journal of 
Haematology. 2011;154(July):680-689
[31] Martinez SL, Clavijo CA, 
Winograd E. Identification of peripheral 
membrane proteins associated with the 
tubo-vesicular network of Plasmodium 
falciparum infected erythrocytes. 
Molecular and Biochemical Parasitology. 
1998;91(2):273-280
[32] Cooke BM, Mohandas N, Coppel RL. 
The malaria-infected red blood cell: 
Structural and functional changes. 
Advances in Parasitology. 2001;50:1-86
[33] Deponte M, Hoppe HC, Lee MCS, 
Maier AG, Richard D, Rug M, et al. 
Molecular & biochemical parasitology 
wherever I may roam: Protein and 
membrane trafficking in P. falciparum-
infected red blood cells. Molecular 
and Biochemical Parasitology. 
2012;186:95-116. DOI: 10.1016/j.
molbiopara.2012.09.007
[34] Mcmillan PJ, Millet C, Batinovic S, 
Maiorca M, Kenny S, Muhle RA, et al. 
Spatial and temporal mapping of the 
PfEMP1 export in pathway Plasmodium 
falciparum. NIH Public Access. 
2014;15(8):1401-1418
[35] Rug M, Prescott SW, Fernandez KM, 
Cooke BM, Cowman AF. The role of 
KAHRP domains in knob formation 
and cytoadherence of P. falciparum-
infected human erythrocytes. Blood. 
2006;108(1):370-378
[36] Chen Q , Schlichtherle M, 
Wahlgren M. Molecular aspects of 
severe malaria. Clinical Microbiology 
Reviews. 2000;13(3):439-450
[37] Goyal M, Alam A, Bandyopadhyay 
U. Redox regulation in malaria: Current 
concepts and Pharmacotherapeutic 
implications. Current Medicinal 
Chemistry. 2012;19:1475-1503
[38] Yam XY, Mbengue A, Braun-breton 
C. Human erythrocyte remodelling 
by Plasmodium falciparum. In: Malaria 
Parasites. Intechopen. 2012. pp. 107-135
[39] Smith JD, Rowe JA, Higgins 
MK, Lavstsen T. Microreview 
Malaria’s deadly grip: Cytoadhesion 
of Plasmodium falciparum-infected 
erythrocytes. Cellular microbiology. 
2013;15(12):1976-1983
[40] Waller KL, Nunomura W, An X,  
Cooke BM, Mohandas N, Coppel RL.  
Brief report Mature parasite-infected 
erythrocyte surface antigen (MESA) 
of Plasmodium falciparum binds to 
the 30-kDa domain of protein 4.1 in 
malaria-infected red blood cells. Blood. 
2003;102(5):1911-1914
[41] Pei X, Guo X, Coppel R, 
Mohandas N, An X. Plasmodium 
falciparum erythrocyte membrane 
protein 3 (PfEMP3) destabilizes 
erythrocyte membrane skeleton. 
The Journal of Biological Chemistry. 
2007;282(37):26754-26758
[42] Enderle T, Ha T, Ogletree DF, 
Chemla DS, Magowan C, Weiss S.  
Membrane specific mapping and 
colocalization of malarial and host 
skeletal proteins in the Plasmodium 
falciparum infected erythrocyte 
by dual-color near-field scanning 
optical microscopy. Proceedings of 
the National Academy of Sciences 
of the United States of America. 
1997;94(2):520-525
[43] Cooke BM, Mohandas N, Coppel 
RL. Malaria and the red blood cell 
membrane. Seminars in Hematology. 
2004;41(2):173-188
[44] Spielmann T, Gilberger T. Critical 
steps in protein export of Plasmodium 
falciparum blood stages. Trends in 
Parasitology. 2015;31(10):514-525. DOI: 
10.1016/j.pt.2015.06.010
[45] Magowan C, Nunomura W, Waller 
KL, Yeung J, Liang J, Van Dort H, et al. 
Ple se use Adobe Acrobat Reader to read this book chapter for free.
Just open this same document with Adobe Reader.
If you do not have it, you can download it here.
You can freely access the chapter at the Web Viewer here.
Securing Connection...Acrobat is locking documen loading.com
r
File cannot be found.
17
Plasmodium falciparum Protein Exported in Erythrocyte and Mechanism Resistance to Malaria
DOI: http://dx.doi.org/10.5772/intechopen.83700
Plasmodium falciparum histidine-rich 
protein 1 associates with the band 
3 binding domain of ankyrin in the 
infected red cell membrane. Biochmica 
Biophys Acta. 2000;1502(3):461-470
[46] Jobe SM, Wilson KM, Leo L,  
Raimondi A, Molkentin JD, 
Steven R, et al. Critical role for the 
mitochondrial permeability transition 
pore and cyclophilin D in platelet 
activation and thrombosis. Blood. 
2014;111(3):1257-1265
[47] Zhang M, Faou P, Maier AG, Rug M. 
Plasmodium falciparum exported 
protein PFE60 influences Maurer’s clefts 
architecture and virulence complex 
composition. International Journal for 
Parasitology. 2017;48(1):83-95. DOI: 
10.1016/j.ijpara.2017.09.003
[48] Nolte D, Hundt E, Langsley G, 
Knapp B. A Plasmodium falciparum 
blood stage antigen highly homologous 
to the glycophorin binding protein 
GBP. Molecular and Biochemical 
Parasitology. 1991;49(2):253-264
[49] Knuepfer E, Rug M, Klonis N, 
Tilley L, Cowman AF. Trafficking 
determinants for PfEMP3 export 
and assembly under the Plasmodium 
falciparum-infected red blood cell 
membrane. Molecular Microbiology. 
2005;58(4):1039-1053
[50] Pasternak ND, Dzikowski R.  
PfEMP1: An antigen that plays a 
key role in the pathogenicity and 
immune evasion of the malaria 
parasite Plasmodium falciparum. The 
International Journal of Biochemistry & 
Cell Biology. 2009;41(7): 
1463-1466. Available from: http://
linkinghub.elsevier.com/retrieve/pii/
S1357272508005098
[51] Niang M, Yam XY, Preiser PR. The 
Plasmodium falciparum STEVOR 
multigene family mediates antigenic 
variation of the infected erythrocyte. 
PLoS Pathogens. 2009;5(2):e1000307
[52] Deponte M, Hoppe HC, Lee MCS, 
Maier AG, Richard D, Rug M, et al. 
Molecular & biochemical parasitology 
wherever I may roam: Protein and 
membrane trafficking in P. falciparum-
infected red blood cells. Molecular 
and Biochemical Parasitology. 
2012;186(2):95-116. DOI: 10.1016/j.
molbiopara.2012.09.007
[53] Spycher C, Klonis N, Spielmann T,  
Kump E, Steiger S, Tilley L, et al. 
MAHRP-1, a novel Plasmodium 
falciparum histidine-rich protein, 
binds ferriprotoporphyrin IX and 
localizes to the Maurer’s clefts. The 
Journal of Biological Chemistry. 
2003;278(37):35373-35383
[54] Mchugh E, Batinovic S, Hanssen E, 
Mcmillan PJ, Kenny S, Griffin MDW, 
et al. A repeat sequence domain of the 
ring-exported protein-1 of Plasmodium 
falciparum controls export machinery 
architecture and virulence protein 
trafficking. Molecular Microbiology. 
2015;98(6):1101-1114
[55] Cserti CM, Dzik WH. The ABO 
blood group system and Plasmodium 
falciparum malaria. Blood. 
2007;110(7):2250-2258. DOI: 10.1182/
blood-2007-03-077602
[56] Sabbatani S, Manfredi R, 
Fiorino S. Malaria infection and the 
anthropological evolution. Saúde 





[57] Bauduer F. Red cell polymorphisms 
and malaria: An evolutionary 
approach. Bulletins et mémoires de 
la Société d’Anthropologie de Paris. 
2013;25(1-2):55-64
[58] Cyrklaff M, Sanchez CP, 
Frischknecht F, Lanzer M. Host actin 
remodeling and protection from malaria 
by hemoglobinopathies. Trends in 
Please use Adobe Acrobat Reade  o read this book chap er for free.
Just open this sam  document with Adobe Reader.
If you do not have it, you can download it here.
You can freely access the chapter at the Web Viewer here.
Securing Connection...Acrobat is l cking docum n loading.com
r
File cannot be found.
Malaria
18
Parasitology. 2012;28(11):479-485. DOI: 
10.1016/j.pt.2012.08.003
[59] López C, Saravia C, Gomez A, 
Hoebeke J, Patarroyo MA. Mechanisms 
of genetically-based resistance to 




[60] Modell B, Darlison M. Global 
epidemiology of haemoglobin disorders 
and derived service indicators. Bulletin 
of the World Health Organization. 
2008;86(6):480-487
[61] Weatherall DJ, Clegg JB. Inherited 
haemoglobin disorders: An 
increasing global health problem. 




[62] Domínguez Y, Zurita C,  
Calvopiña D, Villacís J, Mora 
M. Prevalence of common hemoglobin 
variants in an afro-descendent 
Ecuadorian population. BMC Research 
Notes. 2013;6(1):132. Available 
from: http://www.biomedcentral.
com/1756-0500/6/132
[63] Yusuf HR, Lloyd-Puryear MA, 
Grant AM, Parker CS, Creary MS, 
Atrash HK. Sickle cell disease. American 
Journal of Preventive Medicine. 
2011;41(6):S376-S383. Available from: 
http://linkinghub.elsevier.com/retrieve/
pii/S0749379711006209
[64] Alvear CC, Barboza M, Viola M, 
Moneriz C, Araque LM. Pilot study 
of hemoglobinopathies in newborns 
of the Rafael Calvo maternity clinic 
of Cartagena, Colombia. Estud Pilot 
hemoglobinopatías en recién nacidos 
la Clínica Matern Rafael Calvo Cart 




[65] de Mendonça VRR, Goncalves MS,  
Barral-Netto M. The host genetic 
diversity in malaria infection. Journal 
of Tropical Medicine. 2012;2012:1-17. 
Available from: http://www.hindawi.
com/journals/jtm/2012/940616/
[66] Hedrick PW. Population genetics of 
malaria resistance in humans. Heredity 
(Edinb). 2011;107:283-304. DOI: 
10.1038/hdy.2011.16
[67] Voskou S, Aslan M, Fanis P, 
Phylactides M, Kleanthous M. Oxidative 
stress in β-thalassaemia and sickle cell 
disease. Redox Biology. 2015;6:226-239. 
DOI: 10.1016/j.redox.2015.07.018
[68] Rees DC, Williams TN, Gladwin 
MT. Sickle-cell disease. Lancet. 
2010;376(9757):2018-2031. DOI: 
10.1016/S0140-6736(10)61029-X
[69] Ware KM, Feinstein DL, Rubinstein 
I, Battula P, Otero J, Hebert L, et al. The 
severity of intracranial hemorrhages 
measured by free hemoglobin in the 
brain depends on the anticoagulant 
class: Experimental data. Stroke 
Research and Treatment. 2017;2017:1-4
[70] Ferreira A, Balla J, Jeney V, Balla G, 
Soares MP. A central role for free heme 
in the pathogenesis of severe malaria: 
The missing link? Journal of Molecular 
Medicine. 2008;86(10):1097-1111
[71] Kilian N, Srismith S, Dittmer M, 
Ouermi D, Bisseye C, Simpore J, et al. 
Hemoglobin S and C affect protein 
export in Plasmodium falciparum 
-infected erythrocytes. Biology Open. 
2015:400-410
[72] Alayash AI. Hemoglobin-based 
blood substitutes and the treatment of 
sickle cell disease: More harm than help? 
Biomolecules. 2017;7(1):1-13
[73] Jana S, Meng F, Hirsch RE, 
Friedman JM, Alayash AI. Oxidized 
mutant human hemoglobins S and E 
induce oxidative stress and bioenergetic 
Ple se use Adobe Acrobat Reader to read this book chapter for free.
Just open this same document with Adobe Reader.
If you do not have it, you can download it here.
You can freely access the chapter at the Web Viewer here.
Securing Connection...Acrobat is locking documen loading.com
r
File cannot be found.
19
Plasmodium falciparum Protein Exported in Erythrocyte and Mechanism Resistance to Malaria
DOI: http://dx.doi.org/10.5772/intechopen.83700
dysfunction in human pulmonary 
endothelial cells. Frontiers in 
Physiology. 2017;8(Dec):1-14
[74] Pasvol G, Weatherall D, Wilson R.  
Cellular mechanism for the protective 
effect of haemoglobin S against 
P. falciparum malaria. Nature. 
1978;274(5672):701-703
[75] Pasvol G, Weatherall DJ. The red cell 
and the malarial parasite. British Journal 
of Haematology. 1980;46(2):165-170
[76] Archer NM, Petersen N, 
Clark MA, Buckee CO, Childs 
LM, Duraisingh MT. Resistance to 
Plasmodium falciparum in sickle 
cell trait erythrocytes is driven by 
oxygen-dependent growth inhibition. 
Proceedings of the National Academy of 
Sciences. 2018:201804388. DOI: 10.1073/
pnas.1804388115
[77] Aneni EC, Hamer DH, Gill CJ.  
Systematic review of current and 
emerging strategies for reducing 
morbidity from malaria in sickle 
cell disease. Tropical Medicine & 
International Health. 2013;18(3): 
313-327. Available from: http://www.
ncbi.nlm.nih.gov/pubmed/23320577
[78] Williams TN. Human red blood 
cell polymorphisms and malaria. 
Current Opinion in Microbiology. 
2006;9:388-394
[79] Becker K, Tilley L, Vennerstrom JL,  
Roberts D, Rogerson S, Ginsburg 
H. Oxidative stress in malaria parasite-
infected erythrocytes: Host-parasite 
interactions. International Journal for 
Parasitology. 2004;34:163-189. Available 
from: http://linkinghub.elsevier.com/
retrieve/pii/S002075190300314X
[80] Ayi K, Turrini F, Piga A, Arese P.  
Enhanced phagocytosis of ring-
parasitized mutant erythrocytes: A 
common mechanism that may explain 
protection against falciparum malaria 
in sickle trait and beta-thalassemia 
trait. Blood. 2004;104(10):3364-3371. 
Available from: http://www.ncbi.nlm.
nih.gov/pubmed/15280204
[81] Bunn HF. The triumph of 
good over evil: Protection by the 
sickle gene against malaria. Blood. 
2013;121(1):20-25
[82] Luzzi GA, Merry AH, Newbold CI,  
Marsh KI, Pasvol G. Protection by 
a-thalassaemia against Plasmodium 
falciparum malaria: Modified surface 
antigen expression rather than impaired 
growth or cytoadherence. Immunology 
Letters. 1991;30:233-240
[83] Mockenhaupt FP, Ehrhardt S, 
Gellert S, Otchwemah RN, Dietz E,  
Anemana SD, et al. Brief report 
α+−thalassemia protects African 
children from severe malaria. Blood. 
2004;104(7):2003-2007
[84] Krause MA, Diakite SAS, Lopera-
mesa TM, Amaratunga C, Arie T, 
Traore K, et al. A -thalassemia impairs 
the Cytoadherence of Plasmodium 
falciparum-infected erythrocytes 
methods. PLoS One. 2012;7(5):1-7
[85] Premawardhena A, Arambepola M,  
Samaranayake R, Allen SJ, Peto TEA,  
Fisher CA, et al. Interaction of 
malaria with a common form of severe 
thalassemia in an Asian population. 
PNAS. 2009;106(4):18716-18721
[86] Mockenhaupt FP, Bienzle U, Falusi 
AG, Ademowo OG, Olumese PE, Meyer 
CG. Plasmodium falciparum infection: 
Influence on hemoglobin levels in 
a -thalassemia and Microcytosis. 
The Journal of Infectious Diseases. 
1999;180(September):925-928
[87] Ayi K, Turrini F, Piga A, Arese P.  
Enhanced phagocytosis of ring-
parasitized mutant erythrocytes: A 
common mechanism that may explain 
protection against falciparum malaria 
in sickle trait and beta-thalassemia trait. 
Blood. 2004;104(10):3364-3372
Please use Adobe Acrobat Reade  o read this book chap er for free.
Just open this sam  document with Adobe Reader.
If you do not have it, you can download it here.
You can freely access the chapter at the Web Viewer here.
Securing Connection...Acrobat is l cking docum n loading.com
r
File cannot be found.
Malaria
20
[88] Roberts DJ, Williams TN, Roberts 
DJ, Williams TN. Haemoglobinopathies 
and resistance to malaria. Redox Report. 
2013;8(5):2003
[89] Cockburn IA, Mackinnon MJ, 
Donnell AO, Allen SJ, Moulds JM,  
Baisor M, et al. A human  
complement receptor 1 polymorphism 
that reduces Plasmodium falciparum 
rosetting confers protection 
against severe malaria. PNAS. 
2003;101(1):272-277
[90] Para S, Mungkalasut P, Chanda M,  
Nuchprayoon I, Krudsood S, 
Cheepsunthorn CL. An observational 
study of the effect of hemoglobinopathy, 
alpha thalassemia and hemoglobin E 
on P. Vivax Parasitemia. Mediterranean 
Journal of Hematology and Infectious 
Diseases. 2018;10(1):e2018015
[91] Williams TN, Wambua S, Uyoga S, 
Macharia A, Mwacharo JK,  
Newton CRJC. Brief report both 
heterozygous and homozygousm 
α+thalassemias protect against severe 
and fatal Plasmodium falciparum 
malaria on the coast of Kenya. Blood. 
2005;106(1):368-372
[92] Cappellini MD, Fiorelli G. Glucose-
6-phosphate dehydrogenase deficiency. 
Lancet. 2008;371(9606):64-74
[93] Luzzatto L. Glucose 6-phosphate 
dehydrogenase deficiency: From 
genotype to phenotype. Haematologica. 
2006;91(10):1303-1306
[94] Fonseca D, Mateus H, Silva C, 
Contreras N, Restrepo C.  
Deficiencia de glucosa 6-fosfato 
deshidrogenasa: Aspectos generales de 
la eritroenzimopatía más frecuente en 
el mundo. Acta Médica Colombiana. 
2005;30(2):59-64
[95] Stanton RC. Glucose-6-phosphate 
dehydrogenase, NADPH, and cell 
survival. IUBMB Life. 2012;64(5): 
362-369. DOI: 10.1002/iub.1017
[96] Bonilla J, Sánchez M, Chuaire L.  
Glucosa-6-fosfato deshidrogenasa 
(G6PD). Respuesta de los hematíes y 
otras células humanas a la disminución 
en su actividad. Colombia Médica. 







[97] Ruwende C, Hill A. Glucose-6-
phosphate dehydrogenase deficiency 
and malaria. Journal of Molecular 
Medicine. 1998;76(8):581-588. Available 
from: http://www.ncbi.nlm.nih.gov/
pubmed/9694435
[98] Allahverdiyev AM, Bagirova M,  
Elcicek S. Glucose-6-Phosphate 
Dehydrogenase Deficiency and Malaria: 
A Method to Detect Primaquine-
Induced Hemolysis in Vitro. Intechopen; 
2012
[99] Ginsburg H, Atamna H, Shalmiev 
G, Kanaani J, Krugliak M. Resistance 
of glucose-6-phosphate dehydrogenase 
deficiency to malaria: Effects of fava 
bean hydroxypyrimidine glucosides 
on Plasmodium falciparum growth 
in culture and on the phagocytosis 
of infected cells. Parasitology. 
1996;(113(Pt.1)):7-18
[100] Hwang S, Mruk K, Rahighi S, Raub 
AG, Chen C, Dorn LE, et al. Correcting 
glucose-6-phosphate dehydrogenase 
deficiency with a small-molecule 
activator. Nature Communications. 
2018;9(1):1-12
[101] Luzzatto L, Arese P. Favism and 
glucose-6-phosphate dehydrogenase 
deficiency. The New England Journal 
of Medicine. 2018;378(1):60-71. DOI: 
10.1056/NEJMra1708111
[102] Grace RF, Zanella A, Neufeld EJ, 
Morton DH, Eber S, Yaish H, et al. 
Erythrocyte pyruvate kinase deficiency: 
Ple se use Adobe Acrobat Reader to read this book chapter for free.
Just open this same document with Adobe Reader.
If you do not have it, you can download it here.
You can freely access the chapter at the Web Viewer here.
Securing Connection...Acrobat is locking documen loading.com
r
File cannot be found.
21
Plasmodium falciparum Protein Exported in Erythrocyte and Mechanism Resistance to Malaria
DOI: http://dx.doi.org/10.5772/intechopen.83700
2015 status report. American Journal of 
Hematology. 2015;90(9):825-830
[103] Zanella A, Fermo E, Bianchi P, 
Valentini G. Red cell pyruvate kinase 
deficiency: Molecular and clinical 
aspects. British Journal of Haematology. 
2005;130:11-25
[104] Abdrhamn B, Gibreel M. Human 
genetic factors associated with 
protection against malaria. Iraqi Journal 
of Hematology. 2018;7:97-98
[105] Machado P, Manco L, Gomes C, 
Mendes C, Fernandes N, Salomé G, 
et al. Pyruvate kinase deficiency in 
sub-Saharan Africa: Identification of 
a highly frequent missense mutation 
(G829A; Glu277Lys) and association 
with malaria. PLoS One. 2012:7(10)
[106] Min-oo G, Fortin A, Tam M, 
Nantel A, Stevenson MM, Gros P.  
Pyruvate kinase deficiency in mice 
protects against malaria. Nature 
Genetics. 2003;35(4):357-362
[107] Ayi K, Liles WC, Gros P, Kain KC.  
Adenosine triphosphate depletion of 
erythrocytes simulates the phenotype 
associated with pyruvate kinase 
deficiency and confers protection 
against Plasmodium falciparum In vitro. 
The Journal of Infectious Diseases. 
2009;200:1289-1299
[108] van Bruggen RCG, Iliescu A, 
Cheepsunthorn CL, Mungkalasut P, 
Trape J-F, Modiano D, et al. Modulation 
of malaria phenotypes by pyruvate 
kinase (PKLR) variants in a Thai. 
Population. 2015:1-18
[109] Min-Oo G, Fortin A, Tam M-F, 
Gros P, Stevenson M. Phenotypic 
expression of pyruvate kinase deficiency 
and protection against malaria in a 
mouse model. Genes and Immunity. 
2004;5(3):168-175
[110] Crockett M, Kirby-allen M, Quirt 
I, Gros P, Ph D, Kain KC. Pyruvate 
kinase deficiency and malaria. The 
New England Journal of Medicine. 
2008;358(17):1805-1810
[111] Petz LD, Yam P, Wilkinson 
L, Garratty G, Lubin B, Mentzer 
W. Increased IgG molecules bound 
to the surface of red blood cells of 
patients with sickle cell anemia. Blood. 
1984;64(1):301-304
[112] Skardoutsou A, Voudris KA, 
Mastroyianni S, Vagiakou E, Magoufis 
G, Koukoutsakis P. Moya Moya 
syndrome in a child with pyruvate 
kinase deficiency and combined 
prothrombotic factors. Journal of Child 
Neurology. 2007;22(4):474-478
Please use Adobe Acrobat Reade  o read this book chap er for free.
Just open this sam  document with Adobe Reader.
If you do not have it, you can download it here.
You can freely access the chapter at the Web Viewer here.
Securing Connection...Acrobat is l cking docum n loading.com
r
File cannot be found.
